RE:RE:Let's do some CalculationsI believe, guidance was maintained for one reason.
They saw what happened to ENDP when it was not and
they said, 'let's not go there right now".
I think they will miss that guidance but hopefully we will be sold.
sunshine7 wrote: expect Donnatal sales investment to pay off in the next Q or 2. Q1 is historically the weakest Q. 4 new tuck in products acquired and operational by May 31 (albeit not in the guidance). Yes, I think its doable and more importantly, CXR believes it as well as guidance has been maintained.
fdfd12 wrote:
They are supposed to do $6.29-$6.77 for 2016. Let's say $6.50
Q1 $1.35
Q2 $1.55 (EST)
-----------------
$2.90
now they have 2 Q to do $3.60
That means $1.80 each Q.
I know they said each Q is better as they go on during the year.
Is that asking too much?